Behavioral Problems Related to Attendance Adult Day Care Centers (PROCENDIAS)

Behavioral Intervention to Reduce Resistance in Those Attending Adult Day Care Centers: PROCENDIAS Study. A Randomized Clinical Trial

Adult Day Care Centers (ADCC) offer important relief and rest services for family caregivers. However, some caregivers report that behavioral and psychological symptoms of dementia (BPSD) arise when they prepare dependents for the ADCC, especially when they have dementia. This issue increases stress for caregivers and contributes to a worsening of their mental health and quality of life. The present study evaluates the effectiveness of a behavioral intervention program aimed at reducing the reluctance of the dependent to attend the ADCC. We hope that reducing resistance will have a positive influence on the mental health of caregivers.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Randomized controlled trial. The protocol was performed in accordance with the SPIRIT 2013 Statement and was registered in the Clinical Trials-gov (PROCENDIAS study). The CONSORT guidelines were rigorously followed in this randomized clinical trial. Information about the study, including the objectives, procedures, possible benefits and risks was provided at the beginning of the study and written informed consent, according to the general recommendations of the Declaration of Helsinki (World Medical, 2013), was obtained from each study participant.

Study Population:

The study was conducted in the municipality of Salamanca based on a list of people who attend an ADCC and whose relatives agree to participate voluntarily in the study. The reference population will be people attending ADCC and the relatives who participate in their care and who identify themselves as principal caregivers for this task.

Variables and measurement instruments The data will be collected in an interview, using the questionnaire designed for the study.

  1. Outcome variables:

    Caregiviers:

    Sociodemographic information. The frequency and distress associated with disruptive behaviors was measured with the Spanish version of the disruptive behaviors sub-scale of the Revised Memory and Behavior Problems Checklist (RMBPC), an 8-item scale with answers ranging from 0 (never occurred) to 4 (occurs daily or more often), for the frequency score, and from 0 (not at all) to 4 (extremely), for the distress score.

    Caregivers' mental health as self-perceived by caregivers was measured using the 12-item version of the GHQ-12 (Goldberg & Hillier, 1979). Depressive symptomatology was measured through the Center for Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977), a 20-item scale. Caregiver stress and overload were measured through the short Zarit Burden Interview (short ZBI; Gort et al., 2005). Family function has been measured using the family APGAR test (Smilkstein, 1978).

  2. ADCC Users:

Sociodemographic variables: age, gender, marital status and years of schooling; comorbidity (Charlson's comorbidity index). Functional capacity: basic activities of daily life (Barthel index); instrumental activities of daily living (Lawton-Brody index);

Baseline Evaluation and Follow-Up:

All ADCCs in the city were invited to participate in the study and those centres agreeing to do so sent an information letter about the project to the home of each of their users inviting them to participate in the study. Caregivers who agreed to participate reported at their centre and the centre contacted the research team. Participants received a telephone call from the research team after about 10-15 days to arrange an appointment and perform the baseline evaluation. The assessments were made either at the ADCC or at the relevant health centre. Those that met the inclusion criteria were subsequently selected. Once this phase was finished, the caregiver was assigned to the intervention group (IG) or control group (CG), in accordance with a previously randomised sequence. The assignment sequence was generated by an independent researcher using Epidat 4.2 software (Consellería de Sanidade, 2016) with a 1:2 a ratio. The selected family caregivers were informed that a weekly session of 90 minutes would be held over a period of 8 weeks in groups of 8-10 participants each. Caregivers of relatives with different pathologies were included. The same evaluation was performed for the CG and the IG at baseline and at 6 months after randomisation.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Salamanca, Spain, 37007
        • FUNDACION INFOSALUD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Participants in the study are those family members who help in the care of the person attending the ADCC at least two days a week;
  2. Family caregivers perform or participate in organizing the dependent patient's preparation to visit the ADCC, with or without the help of another person. It is define "preparation for attendance" as all the activities performed by the caregivers in interaction with the patient, from the moment in which they begin to prepare until they get into the vehicle taking them to the ADCC, with the aim of facilitating their ADCC attendance. This includes, for example, waking them up, getting them out of bed, helping them shower and get dressed, assisting them at breakfast, helping them to walk and use the stairs, communicating with them about current actions and what they will be doing in the immediate future;
  3. Family caregivers recognize the existence of at least one BPSD associated with ADCC care;
  4. Signature of informed consent by family caregivers.

Exclusion Criteria:

  1. Paid caregivers;
  2. Family caregivers who do not participate in the preparation for the ADCC visit;
  3. Those who do not sign informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual care
Experimental: Intervention group
behavioral intervention program
The intervention will consist of 8 weekly sessions, with a duration of 90 minutes. Although each intervention is adapted to the specific behavioral problems

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
disruptive behaviors
Time Frame: Post intervention (6 months follow-up assessment will be performed)
Measured by the questionary disruptive behaviors will be measured with RMBPC
Post intervention (6 months follow-up assessment will be performed)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2017

Primary Completion (Actual)

December 12, 2017

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

February 12, 2017

First Submitted That Met QC Criteria

February 15, 2017

First Posted (Actual)

February 17, 2017

Study Record Updates

Last Update Posted (Actual)

November 16, 2022

Last Update Submitted That Met QC Criteria

November 13, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GRS1274/B/16

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Family Members

Clinical Trials on Intervention

3
Subscribe